WORLD TRADE ORGANIZATION  
ORGANISATION MONDIALE DU COMMERCE  
ORGANIZACIÓN MUNDIAL DEL COMERCIO  
 
 
Centre William Rappard    Rue de Lausanne 154    Case postale    CH - 1211 Genève 21 
 Téléphone:  (+41 22) 739 51 11    Fax:  (+41 22) 731 42 06 
Internet:  http://www.wto.org 
  
 
 
 
 
Reference:     WLI/100             11 November 2011  
   
 
  
 
  
MARRAKESH AGREEMENT ESTABLISHING 
THE WORLD TRADE ORGANIZATION 
DONE AT MARRAKESH ON 15 APRIL 1994 
 
GENERAL AGREEMENT ON TARIFFS AND TRADE 1994 
 
CERTIFICATION OF MODIFICATIONS AND RECTIFICATIONS TO  
SCHEDULE XXXVIII - JAPAN 
 
 
TRANSMISSION OF CERTIFIED TRUE COPY 
 
  I have the honour to furnish herewith a certified tr ue copy of the Certification of Modifications 
and Rectifications to Schedule  XXXVIII - Japan,  done 4 November 2011 . 
  
 
  
 
  
 
 
       P a s c a l  L a m y  
       Director-General 
  
 
  
 
 
 
  
 
  
 
 11-5834             WT/Let/835   
 
 
 
  
SCHEDULES OF TARIFF CONCESSIONS TO THE 
GENERAL AGREEMENT ON TARIFFS AND TRADE 1994 
 
CERTIFICATION OF MODIFICATIONS AND RECTIFICATIONS 
 
SCHEDULE XXXVIII - JAPAN 
 
 
WHEREAS the CONTRACTING PARTIES to the G eneral Agreement on Tariffs and Trade 
1947 adopted, on 26 March 1980, a Decision on Procedu res for Modification and Rectification of 
Schedules of Tariff Concessions (BISD 27S/25); 
 
WHEREAS in accordance with the provisions  of the above-mentioned Decision, the draft 
containing modifications and rect ifications to Schedule XXXVIII – Japan was communicated to all 
Members in document G/MA/TAR/RS/291 and G/MA/TAR/RS/291/Corr.1; 
 
IT IS HEREBY CERTIFIED that the modifica tions and rectifications to Schedule XXXVIII – 
Japan are established in conformity  with the above-mentioned Decision. 
 The annexed modifications and rectifications to the Schedule become effective in accordance 
with the notification to be given to that effect by t he Government of Japan to the Director-General of the 
World Trade Organization upon completion of Japan’s internal procedures.   
This Certification is deposited with the Direct or-General of the World Trade Organization, who 
shall promptly furnish a certified true copy thereof to each Member of the World Trade Organization. It 
shall be registered in accordance with the provisions of Article 102 of the Charter of the United Nations. 
 
DONE at Geneva this fourth day of  November, two thousand and eleven. 
   
 
 
     
 
    
 
 
Certified true copy: 
 
 
  
 
  
Director-General 
   
Schedule XXXVIII – Japan Page 5 WT/Let/835   
 
         
MODIFICATIONS AND RECTIFICATIO NS TO SCHEDULE XXXVIII – JAPAN 
 
          
  
Schedule XXXVIII – Japan Page 6 WT/Let/835  
 SCHEDULE XXXVIII – Japan 
                   
4 November 2011 
  
Schedule XXXVIII – Japan Page 7 WT/Let/835  PART I MOST-FAVOURED-NATION TARIFF 
 
SECTION II Other Products 
 Mark the tariff item number 2843.29, 2910.20, 2921.51 with a letter “P”  
Schedule XXXVIII – Japan Page 8 WT/Let/835  
 Attachment to SCHEDULE XXXVIII – JAPAN 
  
Replace “Annexes IA, IB, IC and ID” in catego ry (3) by “Annexes IA, IB, IC, ID and IE”. 
 Replace “Annexes IA, IB, IC and ID” in category (4) by “Annexes IA , IB, IC, ID and IE”, and “Annex II” by “Annexes IIA and IIB” . 
 Replace “Annexes IVA, IVB, IVC and IVD” in categor y (6) by “Annexes IVA, IV B, IVC, IVD and IVE”. 
  
Schedule XXXVIII – Japan Page 9 WT/Let/835  Insert the following Annex after Annex ID  
 
ANNEX IE 
Designated Pharmaceutical Active Ingredie nts (Additions by the fourth review) 
 
HS Subheading  Description  HS Subheading  Description  
2842.90 fermagate 2924.29 firategrast 2843.90 padeliporfin 2924.29 gabapentin enacarbil 2844.40 iodofiltic acid (
123I) 2924.29 incyclinide 
2904.10 eprodisate 2924.29 indantadol 2906.19 elocalcitol 2924.29 levomilnacipran 2909.30 terameprocol 2924.29 lisdexamfetamine 2916.19 peretinoin 2924.29 milveterol 2916.39 tarenflurbil 2924.29 ombrabulin 2918.19 
bevirimat 2924.29 senicapoc 
2919.00 fospropofol 2925.19 pomalidomide 2920.90 naproxcinod 2928.00 olesoxime 2921.19 tramiprosate 2928.00 sivifene 2922.19 afimoxifene 2928.00 tecovirimat 2922.19 ronacaleret 2928.00 tosedostat 2922.22 faxeladol 2928.00 vo
rinostat 
2922.50 amibegron 2929.90 palifosfamide 2922.50 cinaciguat 2930.90 apremilast 2922.50 fasobegron 2930.90 camobucol 2923.10 choline fenofibrate 2930.90 dalcetrapib 2924.29 arbaclofen placarbil 2930.90 darinaparsin 2924.29 
bedoradrine 2930.90 elesclomol 
2924.29 carisbamate 2930.90 elsibucol 2924.29 emricasan 2930.90 ezatiostat 2924.29 eprotirome 2930.90 metenkefalin  
Schedule XXXVIII – Japan Page 10 WT/Let/835  
 HS Subheading  Description  HS Subheading  Description  
2930.90 monepantel 2933.39 befiradol 
2930.90 odanacatib 2933.39 betrixaban 
2930.90 salirasib 2933.39 daporinad 2930.90 succinobucol 2933.39 entinostat 2930.90 tipelukast 2933.39 goxalapladib 2931.00 amsilarotene 2933.39 imisopasem manganese 2932.19 eribulin 2933.39 levamlodipine 2932.19 pafuramidine 2933.39 levonadifloxacin 2932.29 omtrip
tolide 2933.39 migalastat 
2932.99 arterolane 2933.39 motesanib 2932.99 cabazitaxel 2933.39 parogrelil 2932.99 celivarone 2933.39 pexacerfont 2932.99 dapagliflozin 2933.39 pimavanserin 2932.99 dexnebivolol 2933.39 pitolisan
t
2932.99 larotaxel 2933.39 rosonabant 2932.99 levonebivolol 2933.39 taranabant 2932.99 mifamurtide 2933.39 tropantiol 2932.99 vadimezan 2933.39 vapitadine 2933.19 eltrombopag 2933.39 volinaserin 2933.19 niraxostat 2933.49 almorexant 2933.19 palovarotene 2933.49
balamapimod
2933.19 totrombopag 2933.49 besifloxacin
2933.29 catramilast 2933.49 elvitegravi r
2933.29 demiditraz 2933.49 ferroquine2933.29 dulanermin 2933.49 intiquinatine2933.29 lixisenatide 2933.49 nemonoxacin2933.29 rolipoltide 2933.49 neratinib2933.29 velafermin 2933.49 ozenoxacin2933.39 alcaftadine 2933.49 rilapladib2933.39 amifampridine 2933.49 tezampanel 2933.39 anamorelin 2933.49 veliflapon 2933.39 axitinib 2933.59 aderbasib  
Schedule XXXVIII – Japan Page 11 WT/Let/835  HS Subheading  Description  HS Subheading  Description  
2933.59 adipiplon 2933.79 mimopezil 2933.59 alogliptin 2933.79 orvepitant 2933.59 
bafetinib 2933.79 pamapimod 
2933.59 bosutinib 2933.79 paquinimod 
2933.59 cariprazine 2933.79 perampanel 2933.59 casopitant 2933.79 rolapitant 2933.59 cediranib 2933.79 semagacestat 2933.59 cevipabulin 2933.79 voclosporin 2933.59 danusertib 2933.99 aleplasinin 2933.59 darapladib 2933.99
boceprevir 
2933.59 dutacatib 2933.99 brivanib alaninate 
2933.59 fimasartan 2933.99 denagliptin 2933.59 folitixorin 2933.99 denibulin 2933.59 linagliptin 2933.99 diaplasinin 2933.59 macitentan 2933.99 disitertide 2933.59 nilotinib 2933.99 epetirimod 2933.59 olaparib 2933.99 favipiravir 2933.59 otenabant 2933.99 flovagatran 2933.59 riociguat 2933.99 golotimod 2933.59 sitagliptin 2933.99 larazotide 2933.59 sotrastaurin 2933.99 laropiprant 2933.59 talmapimod 2933.99 lorcaserin 2933.59 talotrexin 2933.99 melogliptin 2933.59 ticagrelor 2933.99 obatoclax 2933.59 vicriviroc 2933.99 panobinostat 2933.69 imeglimin 2933.99 piragliatin 2933.79 aplaviroc 2933.99 pyronaridine 2933.79 
bremelanotide 2933.99 rabeximod 
2933.79 carmegliptin 2933.99 rotigaptide 2933.79 dovitinib 2933.99 rusalatide 2933.79 eribaxaban 2933.99 sofigatran 2933.79 ilepatril 2933.99 sotirimod  
Schedule XXXVIII – Japan Page 12 WT/Let/835  
 HS Subheading  Description  HS Subheading  Description  
2933.99 telaprevir 2934.99 bevasiranib 
2933.99 tigapotide 2934.99 capeserod 2933.99 tiplasinin 2934.99 carfilzomib 2933.99 vabicaserin 2934.99 cenersen 2933.99 vernakalant 2934.99 conestat alfa 2934.10 capadenoson 2934.99 custirsen 2934.10 dasatinib 2934.99 derquantel 2934.10 inolitazone 2934.99 dexelvucitabine 2934.10 isavuconazole 2934.99 dilopetine 2934.10 isavuconazonium chloride 2934.99 edoxaban 2934.10 lobeglitazone 2934.99 elacytarabine 2934.10 managlinat dialanetil 2934.99 esreboxetine 2934.10 masitinib 2934.99 fosalvudine tidoxil 2934.10 mirabegron 2934.99 fosaprepitant 2934.10 rosabulin 2934.99 ibodutant 2934.10 sodelglitazar 2934.99 idrabiotaparinux sodium2934.10 teneligliptin 2934.99 imepitoin 2934.20 
bentamapimod 2934.99 inakalant 
2934.20 talarozole 2934.99 lancovutide 2934.99 aclidinium bromide 2934.99 lapaquistat 2934.99 adoprazine 2934.99 lensiprazine 2934.99 agatolimod 2934.99 lificiguat 2934.99 aleglitazar 2934.99 litenimod 2934.99 amolimogene bepiplasmid 2934.99 mipomersen 2934.99 anacetrapib 2934.99 nepidermin 2934.99 apadenoson 2934.99 omacetaxine mepesuccinate2934.99 apilimod 2934.99 pardoprunox 2934.99 apricitabine 2934.99 pramiconazole 2934.99 azilsartan 2934.99 preladenant 2934.99 azilsartan medoxomil 2934.99 prinaberel 2934.99 
bederocin 2934.99 quarfloxin 
2934.99 beperminogene perplasmid 2934.99 radezolid  
Schedule XXXVIII – Japan Page 13 WT/Let/835  HS Subheading  Description  HS Subheading  Description  
2934.99 radiprodil 2935.00 nesbuvir 2934.99 raltegravir 2935.00 oglemilast 2934.99 regrelor 2935.00 pazopanib 2934.99 retosiban 2935.00 relacatib 2934.99 ridaforolimus 2935.00 resatorvid 2934.99 romidepsin 2935.00 tasisulam 2934.99 ropidoxuridine 2935.00 zibotentan 2934.99 sapacitabine 2940.00 ferric carboxymal
tose
2934.99 saracatinib 2940.00 remogliflozin etabonate2934.99 simotaxel 2940.00 sergliflozin etabonate2934.99 taribavirin 3507.90
bucelipase alfa 
2934.99 telatinib 3507.90 pegloticase 2934.99 trabedersen 3507.90 velaglucerase alfa 2934.99 trelanserin 3911.90 azoximer bromide2934.99 velimogene aliplasmid2934.99 viquidacin 2934.99 votucalis 2934.99 zotarolimus 2935.00 apricoxib 2935.00 
begacestat 
2935.00 belinostat 
2935.00 brecanavir 
2935.00 cevoglitazar 2935.00 drinabant 2935.00 giripladib 2935.00 ibipinabant 2935.00 laromustine 2935.00 lodenafil carbonate 2935.00 masilukast 2935.00 mavacoxib 2935.00 mirodenafil 2935.00 nelivaptan  
Schedule XXXVIII – Japan Page 14 WT/Let/835  
 Renumber Annex II as Annex IIA and amend the systematic name of the following prefix or suffix in Annex IIA as follows: 
Annex IIA 
 
Prefixes and Suffixes for Salts, Esters and Hydrates of INNs 
 
Preferred prefix or suffix Synonym Systematic name when different 
aritox  ricin A chain  
 
                
  
Schedule XXXVIII – Japan Page 15 WT/Let/835  Insert the following Annex after Annex IIA: 
Annex IIB１ 
 
Prefixes and Suffixes for Salts, Esters and Hydrates of INNs (Additions by the fourth review) 
 
Preferred prefix or suffix Synonym Systematic name when different
alanetil   [(S)-1-ethoxy-1-oxo-propan-2-yl]amino  
alaninate  L-alaninate 
alapivoxil L-alanyl, [(2,2-dimethylpropanoyl)oxy]methyl 
aldifitox  
 
  
 
 (4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-dioxo pyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl and 
forming an N-benzoyl derivative of a primary am ine group of diphtheria [550-L-phenylalanine]toxin 
from Corynebacterium diphtheriae -(26-560)-peptide  
besudotox   
  
 
 L-lysyl-L-alanyl-L-serylglycylglycine (linker) fusion protein with des-(365-380)-[Asn
364,Val407, 
Ser515,Gln590,Gln606,Arg613]exotoxin A ( Pseudomonas aeruginosa )-(251-613)-peptide (toxin with region 
IA and first 16 residues of region IB deleted)  
ceribate  rac-2,3-dihydroxypropyl carbonate (ester)  
cipecilate cyclohexanecarboxylate ( ester), cyclopropanecarboxylate (ester) 
dalanated des-B30-alanine 
enacarbil  {rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl 
estafenatox  
 
 
  
 
 
 glycylglycyl-L-proline (linker) fusion protein with enterotoxin type A ( Staphylococcus aureus )- 
(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81, 
Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotoxin type E ( Staphylococcus aureus )-(32-230)-peptide 
(synthetic superantigen SEA/E-120)  
etexilate  ethyl, (hexyloxy)carbonyl
fosamil  phosphono 
glucuronide β-D-glucopyranosiduronic acid [oside]  
medocaril [(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl 
paptox  protein PAP ( Phytolacca americana antiviral )  
placarbil  (R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl)  
 
Note 1:Prefixes and suffixes can be combined  (e.g. hydrochloride phosphate ). They can be preceded by a multiplying prefix such as bi, bis, di, hemi,  
      hepta, hexa, mono, penta, sesqui, tetra, tri, tris ...(e. g. diacetate). Synonyms and system atic names can also be used, i n the same way.  
Schedule XXXVIII – Japan Page 16 WT/Let/835  
  
Annex IVC 
 
Additional Products Used for the Manufacture of Finished  Pharmaceutical Products (Additions by the second review) 
 
Delete 2915.39   17-alpha- hydroxy-3,20-dioxopr egna-4,9(11)-diene-21-yl acetate 
Delete 2934.99   (2R,5S)-4-amino-5-fluoro-1-[2-(hydrox ymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 
                
 
  
Schedule XXXVIII – Japan Page 17 WT/Let/835  Annex IVD 
 
Additional Products Used for the Manufacture of Finished Pharmaceutical Products (Additions by the third review) 
 
Delete 2920.90   4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)propanoate 
Delete 2924.29   2-(2-chlorophenyl)-2-hydroxyethyl carbamate Delete 2933.39   3-ethyl 5-methyl 2-[(2-am inoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 
Delete 2933.39   N-methyl-2-{[3-((E)-2-pyridin-2 -ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamide 
Delete 2934.10   N-(2-chloro-6-methylphenyl) -2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazole-5-c arboxamide 
Delete 2934.99   (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine Delete 2934.99   (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1, 3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid 
Delete 2934.99   2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]p iperazin-1-yl}ethyl)-7H-pyrazolo [4,3-e][1,2,4]triazolo[2,3-c]p yrimidin-5-amine 
Delete 2934.99   2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyri din-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamide 
Delete 2934.99   4-amino-5-fluoro-1-[(2R,5S)-5-(hydrox ymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one 
Delete 2934.99   potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-meth yl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethy l]- 
               6-oxo-1,6-dihydropyrimidine-5-olate 
Delete 2935.00   4-[5-(4-fluorophenyl)-3-(trifluor omethyl)pyrazol-1-yl]benzene-1-sulfonamide 
Delete 2935.00   N-(3-methoxy-5-methylpyrazin-2-yl)-2- [4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide 
 
 
      
Schedule XXXVIII – Japan Page 18 WT/Let/835  
 Insert the following Annex after Annex IVD 
Annex IVE 
 
Additional Products Used for the Manufacture of Finished Pharmaceutical Products (Additions by the fourth review) 
 
HS Subheading Description 
2843.29 [4-amino-N-(pyrimidin-2(1H)-ylidene- κN1)benzenesulfonamidato- κO]silver 
2905.39 (2R,3R)-2,3-dimethylbutane-1,4-diyl bis(4-methylbenzenesulfonate) 2905.59 4-chlorobutyl 2-nitrobenzenesulfonate 2909.30 2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene 2909.30 4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether 
2909.30 2-({2-[(6-bromohexyl)oxy]ethoxy}methyl)-1,3-dichlorobenzene 
2909.49 2-[(2,6-dichlorobenzyl)oxy]ethanol 2909.49 2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl methanesulfonate 2909.49 (3R)-3-methoxydecan-1-ol 2909.50 2-[2-(3-methoxyphenyl)ethyl]phenol 2910.20 (2R)-2-methyloxirane 
2910.90 (2R)-2-(3-chlorophenyl)oxirane 
2910.90 [(2R)-2-methyloxiran-2-yl ]methyl 4-nitrobenzenesulfonate 
2910.90 (2R)-2-[(5-bromo-2,3-difluorophenoxy)methyl]oxirane 2913.00 4'-(trifluoromethyl)biphenyl-4-carbaldehyde 2914.40 (3 β)-3-hydroxycholest-5-en-24-one 
2914.50 (3 β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-one 
2914.70 6-chlorohexan-2-one 
2914.70 4-chloro-heptane-3,5-dione 2915.60 iodomethyl pivalate 2915.90 sodium 2-propylpentanoate 2915.90 (3R)-3-methylhexanoic acid 2916.20 trans-4-(propan-2-yl)cyclohexanecarboxylic acid  
Schedule XXXVIII – Japan Page 19 WT/Let/835  HS Subheading Description 
2916.20 1-(2-ethylbutyl)cycl ohexanecarbonyl chloride 
2916.20 1-(2-ethylbutyl)cyclohexanecarboxylic acid 2916.39 sodium hydrogen 3-sulfonatobenzoate 2916.39 5-fluoro-2-methylbenzoyl chloride 2917.19 diethyl ethyl(pentan-2-yl)propanedioate 
2918.29 5'-chloro-2'-hydroxy-3'-nitrobiphenyl-3-carboxylic acid 
2918.90 (3 α,5β)-3-hydroxy-7-oxocholan-24-oic acid 
2918.90 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid 2918.90 ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoate 2918.90 methyl 3-(5-{[4-(cyclopentyloxy)-2-hyd roxyphenyl]carbonyl}-2-hydroxyphenyl)propanoate 
2918.90 (3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid 
2920.90 5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide  
2920.90 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one 2921.49 2-chlorobenzylamine 2921.49 (1R)-1-[3,5-bis(trifluorom ethyl)phenyl]-N-methylethanamine 
2921.49 (1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate 2921.49 2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride 
2921.49 N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine 
2921.49 2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride 2921.51 N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-benzenediamine 2922.19 [2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride 2922.19 antimonic acid -- 1-deoxy-1-(methylamino)-D-glucitol (1:1) 
2922.19 
 ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}- 
4,5-difluorophenyl)propanoate hydrochloride 
2922.19  ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}- 
4,5-difluorophenyl)prop-2-enoate hydrochloride 
2922.19 
 (2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-dihydro-1H -inden-2-yl)-2-methylpropan-2-yl]amino}propan-2-ol 
hydrochloride 
2922.29 2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamine 
2922.49 methyl 2-(dimethylamino)-2-phenylbutanoate  
Schedule XXXVIII – Japan Page 20 WT/Let/835  
 HS Subheading Description 
2922.49 N-[(2S)-1-ethoxy-1-oxo pentan-2-yl]-L-alanine 
2922.49 sodium 2-amino-2-phenylbutanoate 2922.49 4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid 2922.49 methyl 3'-aminobiphenyl-3-carboxylate 2922.49 (3S,5R)-3-amino-5-methyloctanoic acid hydrochloride 
2922.49 (3S,5R)-3-amino-5-methyloctanoic acid 
2922.49 (2E)-4-(dimethylamino)but-2-enoic acid hydrochloride 2922.49 4-fluoro-L-leucine -- ethyl hydrogen sulfate (1:1) 
2922.50 
 triphenylacetic acid -- 4-{(1R)-2-[(6-{2-[(2, 6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]- 
1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) 
2924.19 N-(2-chloroethyl)acetamide 
2924.19 2-aminomalonamide 2924.29 N-benzyloxycarbonyl-L-alanine 2924.29 ethyl 3-[(5-chloro-2-nitrophe nyl)(phenyl)amino]-3-oxopropanoate 
2924.29 N-cyclohexyl-5-hydroxypentanamide 
2924.29 4-{[(2-methylphenyl)carbonyl]amino}benzoic acid 
2924.29 4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic acid 2924.29 4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorobenzoic acid 2924.29 ethyl {4-[(4-fluorobenzyl)amino]-2-nitrophenyl}carbamate 2924.29 2-chloro-4-{[(5-fluoro-2-methylphenyl)carbonyl]amino}benzoic acid 2924.29 2,3-diaminobenzamide dihydrochloride 
2924.29 
 methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]- 
2-hydroxycyclopentanecarboxylate 
2924.29 2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoic acid 
2924.29 {2-[(tert-butoxycarbonyl)amino]-3-hydrox ytricyclo[3.3.1.1(3,7)]dec-1-yl}acetic acid 
2924.29 propyl {4-[2-(diethylamino )-2-oxoethoxy]-3-ethoxyphenyl}acetate 
2925.19 ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dih ydro-2H-isoindol-2-yl)ethoxy]but-2-enoate 
2926.90 4-(bromoacetyl)benzonitrile 2926.90 5-hydroxybenzene-1,3-dicarbonitrile 2926.90 methyl 2-{[(2'-cyanobiphenyl- 4-yl)methyl]amino}-3-nitrobenzoate  
Schedule XXXVIII – Japan Page 21 WT/Let/835  HS Subheading Description 
2926.90 4,5-diethoxy-3-fluorobenzene-1,2-dicarbonitrile 
2926.90 3-cyclopentylprop-2-enenitrile 2926.90 2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide 2926.90 1-(2-ethylbutyl)cyclohexanecarbonitrile 2928.00 tert-butyl (2Z)-2-[(2-methox y-2-oxoethoxy)imino]-3-oxobutanoate 
2928.00 4-chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid 
2928.00 N,2-dihydroxy-4-methylbenzamide 2928.00 tert-butyl-2-[(2-methoxy- 2-oxoethoxy)imino]-3-oxobutanoate 
2928.00 ethyl (2Z)-chloro[2-(4-methoxyphenyl)hydrazinylidene]ethanoate 2928.00 1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate 2928.00 2-hydroxy-2-(trifluoromethyl)butanehydrazide 
2930.90 {2-[(4-chlorophenyl)sulfanyl]phenyl}acetic acid 
2930.90 N-methylbenzenecarbothiohydrazide 2930.90 3,4-diethoxybenzenecarbothioamide 2930.90 1-(2-ethylbutyl)-N-(2-sulfa nylphenyl)cyclohexanecarboxamide 
2930.90 1-{[(methylsulfanyl)carbony l]oxy}ethyl 2-methylpropanoate 
2930.90 2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethanone 
2931.00 (2-bromoethenyl)(trimethyl)silane 
2931.00 (5-chloro-2-methoxyphenyl)boronic acid 2931.00 2-(1,3,2-dioxaborinan-2-yl)benzonitrile 2931.00 methyl 3-(trimethylsilyl)pent-4-enoate 
2931.00 
 [(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-met hoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1- 
yl]methanol 
2931.00 {(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol 
2931.00 1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea 2931.00 (4R)-2-bromo-7-{[tert-butyl(diphenyl)sily l]oxy}hept-1-en-4-yl 4-methylbenzenesulfonate 
2931.00 (2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamide 
2931.00 (2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamide 
2932.19 
 (1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2- 
[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrof uran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-  
Schedule XXXVIII – Japan Page 22 WT/Let/835  
 HS Subheading Description 
8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol 
2932.19 
 
 (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S, 26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-
2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo 
[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35 ]hentetracontan-24-one methanesulfonate 
2932.29 4-(4-fluorophenyl)-7-(isothio cyanatomethyl)-2H-chromen-2-one 
2932.29 2-oxo-2H-chromene-6-carboxylic acid 2932.29 1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one 2932.29 (4S)-4-(fluoromethyl)dihydrofuran-2(3H)-one 
2932.29 6-[(2,4-dimethoxyphenyl) carbonyl]-2H-chromen-2-one 
2932.29 6-[(2,4-dihydroxyphenyl) carbonyl]-2H-chromen-2-one 
2932.99 2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane 2932.99 disodium 5,5'-[(2-hydroxypropane-1,3-diy l)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate) 
2932.99 
 (1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6 S,7R,8S,8aR)-7,8-bis(benzyloxy)- 
2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetate 
2932.99  methyl (2S,3S,4S,5S,6S)-6-{[( 1S,2S,3S,4R,5R)-3-(acetyloxy)-4- azido-6,8-dioxabicyclo[3.2.1] 
oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate 
2932.99 
 methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl- α-L-idopyranuronosyl)-3-O- 
benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy- α-D-glucopyranoside 
2932.99 5-(chloromethyl)-6-methyl-1,3-benzodioxole 
2932.99 1,6-di-O-acetyl-2-azido-3,4-di -O-benzyl-2-deoxy-D-glucopyranose 
2932.99 
 
 [6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-m etoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-
4-O-phosphono- β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]- α-D-glucopyranose 1-(dihydrogen phosphate) 
tetrasodium sal
t
2932.99 (2E)-1,2,6,7-tetrahydro-8H-inde no[5,4-b]furan-8-ylideneethanenitrile 
2932.99 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5, 4-b]furan-8-yl]ethanamine hydrochloride 
2932.99 ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy ]-3a,6,7,7a-tetrahydro-1,3 -benzodioxole-5-carboxylate 
2932.99 
 [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl] 
carbamate 
2932.99 (1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol 
2932.99 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1- [4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol 
2932.99 
 2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl} 
carbamate  
Schedule XXXVIII – Japan Page 23 WT/Let/835  HS Subheading Description 
2932.99 6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol 
2932.99 
 but-2-yne-1,4-diol -- methyl 1-C-[4 -chloro-3-(4-ethoxybenzyl)phenyl]- 
α-D-glucopyranoside (1:1) 
2933.19 2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one 
2933.19 5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile 2933.19 5-methyl-1-(propan-2-yl)-4-[4-(propan-2- yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one 
2933.19 3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide 
2933.19 
 (4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4, 5-dihydro-1H-pyrazole-1-carboximidamide 
2,3-dihydroxybutanedioate 
2933.29 2-chloro-4-nitro-1H-imidazole 
2933.29 2-bromo-4-nitro-1H-imidazole 
2933.29 
 L-α-aspartyl-L- α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl- 
L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L -threonyl-L-prolyl-L-arginyl-L-threonine 
2933.29 methyl 3'-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylate 
2933.29 
 
 L-α-aspartyl-L- α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L
-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isole ucyl-L-valyl-L-threonyl-L-pr olyl-L-arginyl-L-threonine 
tetraacetate 
2933.29 
 3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbon yl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl- 
L-α-glutamylglycine 
2933.39 (3aR,6aR)-1-(pyridin-3-yl)octahydropyrro lo[3,4-b]pyrrole 4-methylbenzenesulfonate 
2933.39 N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]- 2,6-dichloro-3-(trifluoromethyl)benzamide hydrochloride 
2933.39 5-chloropyridin-2-amine  
2933.39 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)e thyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 
2933.39 1-(pyridin-4-yl)pyridinium chloride hydrochloride 
2933.39 (S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 
2933.39 ethyl [(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetate 2933.39 4-[(3-nitropyridin-2-yl)amino]phenol 2933.39 4-(ethylamino)piperidine-4-carboxamide 
2933.39 
 3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-1,3 -dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-
dihydropyridine-3,5-dicarboxylate 
2933.39 [(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol  
Schedule XXXVIII – Japan Page 24 WT/Let/835  
 HS Subheading Description 
2933.39 2-[methyl(pyridin-2-yl)amino]ethanol 
2933.39 2-[(2-chloro-4-nitrophenoxy)methyl]pyridine 
2933.39 
 1,1'-binaphthalene-2,2'-diol --5-methoxy- 2-{(S)-[(4-methoxy-3,5-dimethylpyridin- 
2-yl)methyl]sulfinyl}-1H-benzimidazole(1:1) 
2933.39 6-(chloroacetyl)pyridine-2-carboxylic acid 
2933.39 sodium hydrogen [1-hydroxy-1-phosphono-2-(p yridin-3-yl)ethyl]phosphonate hemipentahydrate 
2933.39 (3R)-piperidin-3-amine dihydrochloride 
2933.39 (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole dihydrochloride 2933.39 benzyl 2-(4-fluoro-2-methylphenyl)-4-o xo-3,4-dihydropyridine-1(2H)-carboxylate 
2933.39 (2S)-hydroxy(phenyl)ethanoic acid -- (2R)-2-(4-fluoro-2-methylphenyl)piperidin-4-one (1:1) 
2933.39 
 N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin -4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}- 
4-hydroxyphenyl)acetamide 
2933.39 
 7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b] 
indole-1-carboxamide 
2933.39  4-hydroxybenzoic acid -- (2S,4E)-N-methyl-5-[5 -(propan-2-yloxy)pyridin-3-yl]pent-4-en- 
2-amine (1:1) 
2933.39 (2R)-phenyl[(2R)-piperidin-2-yl]ethanoic acid hydrochloride 
2933.39 4-{4-[4-(trifluoromethoxy)phenoxy]piperi din-1-yl}phenol 4-methylbenzenesulfonate 
2933.39 
 1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro- 1H-benzimidazol-1-yl]carbonyl}amino)methyl] 
piperidin-1-yl}methyl)cyclobutanecarboxylic acid 
2933.39 1-[(4-{[(tert-butoxycarbonyl)amino]methyl}p iperidin-1-yl)methyl]cyclobutanecarboxylic acid 
2933.39 4,4'-[piperidine-1,4-diylbis(propane-3,1 -diyloxy)]bis(N'-hydroxybenzenecarboximidamide) 
2933.39 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]di benzenecarboximidamide trihydrochloride pentahydrate 
2933.39 4,4'-[piperidine-1,4-diylbis(propane-3,1-d iyloxy)]bis[N'-(acetyloxy )benzenecarboximidamide] 
2933.39 4,4'-[piperidine-1,4-diylbis(p ropane-3,1-diyloxy)]dibenzonitrile 
2933.39 5,6-dichloro-N-(2,2-dimethoxyethyl)pyridin-3-amine 
2933.39 [(3S,4S)-4-amino-1-(5,6-dichloropyridin-3-yl)pyrrolidin-3-yl]methanol 2933.39 (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6- diazabicyclo[3.2.0]heptane benzenesulfonate 
2933.39 (+)-5-[6-(1-methyl-1H-pyrazol-4-yl)p yridin-3-yl]-1-azabicyclo[3.2.1]octane 
2933.39 4-bromo-2,6-diethylpyridine 4-methylbenzenesulfonate 2933.39 3,3'-piperidine-1,4-diyldipr opan-1-ol 4-methylbenzenesulfonate  
Schedule XXXVIII – Japan Page 25 WT/Let/835  HS Subheading Description 
2933.39 2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 2,3-dihydroxybutanedioate 
2933.39 (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride 
2933.49 
 methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin -2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl) 
cyclopropyl]methyl}sulfanyl)propyl]benzoate hydrochloride 
2933.49 benzyl (3S)-6,7-dimethoxy-1,2,3,4-tetrah ydroisoquinoline-3-carboxylate hydrochloride 
2933.49 
 (3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinoline-3-carboxylic acid -- 
(1R)-1-phenylethanamine (1:1) 
2933.49 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy }-7-methoxyquinoline-6-carboxamide methanesulfonate 
2933.49 
 (3S,4aS,6S,8aR)-6-[3-chloro-2-(2H- tetrazol-5-yl)phenoxy]decahydro-3- 
isoquinolinecarboxylic acid hydrochloride 
2933.49 
 2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-tetrazol-5-yl)phenoxy]decahydro- 
3-isoquinolinecarboxylate 4-methylbenzenesulfonate 
2933.49 (3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycar bonyl)decahydroisoquinoline-3-carboxylic acid 
2933.49 N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide 
2933.49 
 4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amin o]-2-methyl-3,4-dihydr oquinolin-1(2H)-yl] 
carbonyl}phenoxy)-2,2-dimethylbutanoic acid 
2933.49 
 methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin -2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl) 
cyclopropyl)methyl)sulfanyl)propyl)benzoate 
2933.59 
 5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methy lpiperazin-1-yl)[1,2,4]triazolo[1,5-a] 
quinoline-4-carbonitrile -- (2E)-but-2-enedioate (2:1) hydrate 
2933.59 N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-met hyl-2-(pyridin-2-yl)pyrimidine-5-carboxamide 
2933.59 
 2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic acid -- ethyl [(8R)-8-(3,5-difluorophenyl)- 
10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetate (1:1) 
2933.59 4,6-dichloro-2-methylpyrimidine 
2933.59 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 2933.59 2,4-dichloropyrimidine 2933.59 4-methylpiperazine-1-carbonyl chloride hydrochloride 2933.59 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde 
2933.59 4-cyclopentylpiperazin-1-amine 
2933.59 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine 2933.59 4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine  
Schedule XXXVIII – Japan Page 26 WT/Let/835  
 HS Subheading Description 
2933.59 7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one 
2933.59 {2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetr ahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic acid 
2933.59 N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine 
2933.59 2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7- tetrahydro-4H-cyclopenta[d]pyrimidin-4-one 
2933.59 
 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3 -d]pyrimidin-4-yl)amino]piperidin-1-yl}- 
3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate 
2933.59  2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoeth yl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl] 
amino}ethyl dihydrogen phosphate 
2933.59 2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dih ydropyrimidin-1(2H)-yl)methyl]benzonitrile 
2933.59 
 (3,3-difluoropyrrolidin-1-yl){(2S ,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl} 
methanone 
2933.59 
 2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]a mino}-2-methoxypyrimidin-4-yl)phenyl]- 
2-methylpropanoic acid phosphate 
2933.59 (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]p yrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile 
2933.59 4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine 
2933.59 
 3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methy l}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl] 
propanenitrile 
2933.59 
 (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsily l)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin- 
4-yl)-1H-pyrazol-1-yl]propanenitrile 
2933.59  (3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsily l)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin- 
4-yl)-1H-pyrazol-1-yl]propanenitrile 
2933.59 [(8R)-8-(3,5-difluorophenyl)-10-o xo-6,9-diazaspiro[4.5]dec-9-yl]acetic acid 
2933.59 
 2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethy l(phenyl)silyl]-2-methylidenecyclopentyl}-1,9-dihydro- 
6H-purin-6-one -- meth anesulfonate (2:1) 
2933.59 
 3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoic acid -- 
1,4-diazabicyclo[2.2.2]octane (2:1) 
2933.79 4-(bromomethyl)quinolin-2(1H)-one 
2933.79 4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione 2933.79 3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine 
2933.79 7-hydroxy-3,4-dihydroquinolin-2(1H)-one 
2933.79 6-hydroxy-3,4-dihydroquinolin-2(1H)-one  
Schedule XXXVIII – Japan Page 27 WT/Let/835  HS Subheading Description 
2933.79 (1S)-1-amino-3-methyl-1,3,4,5-tetrah ydro-2H-3-benzazepin-2-one hydrochloride 
2933.79 
 ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopipe ridin-1-yl)phenyl]-4,5,6,7-tetrahydro- 
1H-pyrazolo[3,4-c]pyridine-3-carboxylate 
2933.79 
 ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo 
[3,4-c]pyridine-3-carboxylate 
2933.79 3-chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one 
2933.79 methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate 
2933.79 
 (-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}- 
N,4-dimethylbenzamide 
2933.79 
 (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido 
[2,1-a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one dihydrochloride 
2933.99 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride 
2933.99 5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide 2933.99 methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate 2933.99 2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 
2933.99 
 N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asp araginyl-S-benzyl-L- cysteinyl-L-prolyl- 
L-leucylglycinamide 
2933.99 1-(2-nitrobenzyl)-1H-pyrrole-2-carbaldehyde 
2933.99 1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one 
2933.99 (2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid 
2933.99 9H-carbazol-4-ol 2933.99 3-oxo-3,4-dihydropyrazine-2-carboxamide 2933.99 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole 2933.99 8,9-difluoro-5-methyl-1-oxo-6,7-dihydro- 1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid 
2933.99 (2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid 
2933.99 benzyl (2S,3aS,6aS)-octahydrocyclope nta[b]pyrrole-2-carboxylate hydrochloride  
2933.99 
 ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro- 
1,8-naphthyridine-3-carboxylate 
2933.99 ethyl 6-bromo-5-hydroxy-1-methyl-2-[( phenylsulfanyl)methyl]-1H-indole-3-carboxylate 
2933.99 methyl 1-[(2'-cyanobiphenyl-4-yl)met hyl]-2-ethoxy-1H-benzimidazole-7-carboxylate 
2933.99 benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate hydrochloride  
Schedule XXXVIII – Japan Page 28 WT/Let/835  
 HS Subheading Description 
2933.99 3,3-difluoropyrrolidine hydrochloride 
2933.99 1-(tert-butoxycarbonyl)-2-methyl-D-proline 
2933.99 
 3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-di hydro-1H-indol-1-yl}propyl benzoate  
(2R,3R)-2,3-dihydroxybutanedioate 
2933.99 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide 
2933.99 6-iodo-1H-indazole 2933.99 4-fluoro-2-methyl-1H-indol-5-ol 2933.99 tert-butyl (1S,3S,5S)-3-carbamoyl -2-azabicyclo[3.1.0]hexane-2-carboxylate 
2933.99 2,3-dimethyl-2H-indazol-6-amine 
2933.99 5-(2-chloro-6-fluorophenyl)-2H-tetrazole 
2933.99 
 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl- 
1H-benzimidazole-6-carboxamide 
2933.99 
 (2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]- 
2-hydroxyethanoyl}azetidine-2-carboxamide -- benzenesulphonic acid (1:1) 
2933.99  (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin- 
6-yl}oxy)propan-2-ol 
2933.99 tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate 
2933.99 
 tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azab icyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo 
[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate 
2933.99 (1S,3S,5S)-2-azabicyclo[3.1.0]h exane-3-carboxamide methanesulfonate 
2933.99 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea 2933.99 5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate 2933.99 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide 2933.99 2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride 2933.99 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide 
2933.99 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide 
2933.99 
 (2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic acid -- ethyl (3aR,6aR)-hexahydropyrrolo 
[3,4-b]pyrrole-5(1H)-carboxylate (1:1) 
2933.99 
 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl   
2,2-dimethylpropanoate 
2933.99 (5S,8S,11S,14S,17S,20S,23S,26S,29S,32S ,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-  
Schedule XXXVIII – Japan Page 29 WT/Let/835  HS Subheading Description 
 
   [(2S)-
butan-2-yl]-14,38- bis{4-[(ter t-butoxycarbonyl)amino]butyl}-29-{[1-(ter t-
butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41- pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21, 24,27,30,33,36,39-tridecaoxo- 35-(propan-2-yl)-2-oxa- 
4,7,10,13,16,19,22,25, 28,31,34,37,40-tridecaazadot etracontan-42-oic acid
2933.99 
 ethyl 2-amino-9,10-dimethoxy-1,6,7,11b- tetrahydro-4H-pyrido[2,1-a]isoquinoline- 
3-carboxylate 
2933.99 6-fluoro-3-oxo-3,4-dihydropyrazine-2-car bonitrile -- N-cyclohexylcyclohexanamine (1:1) 
2934.10 (2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid 
2934.10 (2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethanoic acid 
2934.10 sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate 2934.10 (5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione 
2934.10 
 N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2 -methylpyrimidin-4-yl)amino]-1,3-thiazole- 
5-carboxamide 
2934.10 2-amino-N-(2-chloro-6-methyl phenyl)-1,3-thiazole-5-carboxamide 
2934.10 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-c yclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl- 
N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine 
2934.10 
 3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]- 
1,2,4-oxadiazol-5(4H)-one 
2934.10 
 L-lysine -- {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol- 2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol- 
1-yl)butan-2-yl]oxy}methyl dihydrogen phosphate -- ethanol (1:1:1) 
2934.99  1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)- 
1,3-dihydro-2H-benzimidazol-2-one 
2934.99 5-bromo-1-benzothiophene 
2934.99 4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)pro pyl]-4-methylmorpholin-4-ium methyl sulfate 
2934.99 (1-benzothiophen-5-yl)acetic acid 2934.99 3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide 2934.99 methyl 3-(chlorosulfonyl)thiophene-2-carboxylate 
2934.99 
 diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4 -methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo 
[3.2.0]hept-2-en-6-yl]but-3-enoate 
2934.99 methyl 3-amino-4-methylthiophene-2-carboxylate 
2934.99 2-(1-benzothiophen-5-yl)ethanol 
2934.99 N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}acetamide  
Schedule XXXVIII – Japan Page 30 WT/Let/835  
 HS Subheading Description 
2934.99 S-[(1R,3S)-1-oxidotetrahydr othiophen-3-yl] ethanethioate 
2934.99 1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole 2934.99 (S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol  2934.99 (3S)-N,N-dimethyl-3-(naphthalen-1- yloxy)-3-(thiophen-2-yl)propan-1-amine 
2934.99 
 (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16, 22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-
1,7,13,19-tetraoxa-4,10,16, 22-tetraazacyclotetracosane-2, 5,8,11,14,17,20 ,23-octone 
2934.99  (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro- 
5-methyltetrahydrofuran-3,4-diyl diacetate 
2934.99 
 (3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro- 3-methyl-7-oxo-2,3-dihy dro-7H-[1,4]oxazino 
[2,3,4-ij]quinoline-6-carboxylic acid 
2934.99 
 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran- 2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione -- 
1-methylpyrrolidin-2-one (1:1) 
2934.99 4-chloro-3-methyl-1,2-oxazol-5-amine 
2934.99 (2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine] 
2934.99 
 (2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine]  
(S,S)-2,3-dihydroxybutanedioate 
2934.99 
 
 (3-{[(2R,3S)-2-{(1R)-1-[3,5-
bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-
2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid -- 1-deoxy-1- 
(meth ylamino )-D-glucitol (1:2)
2934.99 3-oxo-4-( β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide 
2934.99 
 2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2 -(propylsulfanyl)pyrimidin-4-yl]amino}- 
2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol 
2934.99  5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl] amino]-6-quinazolinyl]-2-furancarboxaldehyde -- 
4-methylbenzenesulfonate (1:1) 
2934.99 
 N,N',N''-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo- 
3-phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide 
2934.99 (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one 
2934.99 2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone 
2934.99 3-oxo-4-(2,3,5-tri-O-acetyl- β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide 
2934.99 
 (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin- 
6-yl)-1,3-oxazolidin-2-one 
2934.99 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl ]-3-azetidinol -- (2Z)-2-butenedioate (1:1)  
Schedule XXXVIII – Japan Page 31 WT/Let/835  HS Subheading Description 
2934.99 3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid 
2934.99 3-[2-(1-benzothiophen-5-yl)ethoxy] -1-(3-hydroxyazetidin-1-yl)propan-1-one 
2934.99 
 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl) 
methoxy]phenyl)propanoic acid 
2934.99 
 
 (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R, 9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-
6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)- 
3-hydroxypentan-2- yl]-D-er ythropentitol
2934.99 
 4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tet rahydrofuran-2-yl]-5-thia-1-azabicyclo 
[4.2.0]oct-2-ene-2-carboxylate hydrochloride 
2934.99 
 DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T- 
sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T) 
2934.99  (2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido- 2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran- 
3,4-diyl bis(2-methylpropanoate) hydrochloride 
2934.99 
 2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy} 
methyl)-6-methylbenzoic acid 
2934.99 3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine 
2934.99 
 {(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl) 
oxy]tetrahydrofuran-2-yl}methyl 3-chlorobenzoate 
2934.99 
 4-[4-({3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl} 
methyl)phenyl]-N-[1,3-dihydroxy-2-(h ydroxymethyl)propan-2-yl]butanamide 
2934.99  (6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl )ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a] 
pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one 
2934.99 
 N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-pi perazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]- 
4-quinazolinamine -- (2E )-2-butenedioate (1:2) 
2934.99 
 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]- 
1Hbenzimidazole, sodium salt (1:1) 
2934.99  
 methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo- 
6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro- 
1H,5H-2,23:5,8-dimethano-4, 13,2,8,11-benz odioxatriazacyclohenicosine-7(3H)-carboxylate 
2934.99 6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one 
2934.99 6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one 
2934.99 methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl] -2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on-  
Schedule XXXVIII – Japan Page 32 WT/Let/835  
 HS Subheading Description 
 6-yl)methoxy]phenyl]propionate 
2934.99 
 DNA (synthetic plasmid vector pCOR human interfe ron beta signal peptide fusion protein with  
21-154-human acidic fibroblast growth factor-specifying) 
2934.99 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 
2935.00 
 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2- yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide 
di[(2E)-but-2-enedioate] hydrate 
2935.00 5-amino-2-methylbenzenesulfonamide 
2935.00 1-[(4-methylphenyl)sulfonyl]-1,2 ,3,4-tetrahydro-5H-1-benzazepin-5-one 
2935.00 
 (2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydraziny l-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)
-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamide 
2935.00 N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide 
2935.00 N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide hydrochloride 
2935.00 N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide 2935.00 N-[4-(N-formylglycyl)-5-hydrox y-2-phenoxyphenyl]methanesulfonamide 
2935.00 7-chloro-1-[(4-methylphenyl)sulfonyl ]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one 
2935.00 
 N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}- 
N-methylmethanesulfonamide 
2935.00 3-[(methylsulfonyl)amino]-2-phenyl-N -[(1S)-1-phenylpropyl]quinoline-4-carboxamide 
2935.00 
 (1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium  
4-methylbenzenesulfonate 
2940.00 1,2,3,4,6-penta-O-acetyl- β-D-glucopyranose 
2940.00 2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside 
3907.20 
   poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N6, 21’N6-[[(N2, N6-dicarboxy-
L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl- 
L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-th reonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl- 
L-glutaminyl-L-prolyl-L-leucyl-L-arginyl -N-methylglycyl-L-lysinamide] cyclic (6 →15), (6’→15’) bis(disulfide)
 
 
 
__________